01 1Sms Lifesciences
01 1FUROSEMIDE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-10-08
Pay. Date : 2024-09-24
DMF Number : 39960
Submission : 2024-07-13
Status : Active
Type : II
20
Sms Lifesciences India Ltd, based in India, is a pharmaceutical company.
One of their notable products is FUROSEMIDE USP, with a corresponding US DMF Number 39960.
Remarkably, this DMF maintains an Active status since its submission on July 13, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 08, 2024, and payment made on September 24, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
